Unknown

Dataset Information

0

NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells.


ABSTRACT:

Background

RASSF1A, a tumor suppressor gene, is frequently inactivated in lung cancer leading to a YAP-dependent epithelial-mesenchymal transition (EMT). Such effects are partly due to the inactivation of the anti-migratory RhoB GTPase via the inhibitory phosphorylation of GEF-H1, the GDP/GTP exchange factor for RhoB. However, the kinase responsible for RhoB/GEF-H1 inactivation in RASSF1A-depleted cells remained unknown.

Methods

NDR1/2 inactivation by siRNA or shRNA effects on epithelial-mesenchymal transition, invasion, xenograft formation and growth in SCID-/- Beige mice, apoptosis, proliferation, cytokinesis, YAP/TAZ activation were investigated upon RASSF1A loss in human bronchial epithelial cells (HBEC).

Results

We demonstrate here that depletion of the YAP-kinases NDR1/2 reverts migration and metastatic properties upon RASSF1A loss in HBEC. We show that NDR2 interacts directly with GEF-H1 (which contains the NDR phosphorylation consensus motif HXRXXS/T), leading to GEF-H1 phosphorylation. We further report that the RASSF1A/NDR2/GEF-H1/RhoB/YAP axis is involved in proper cytokinesis in human bronchial cells, since chromosome proper segregation are NDR-dependent upon RASSF1A or GEF-H1 loss in HBEC.

Conclusion

To summarize, our data support a model in which, upon RASSF1A silencing, NDR2 gets activated, phosphorylates and inactivates GEF-H1, leading to RhoB inactivation. This cascade induced by RASSF1A loss in bronchial cells is responsible for metastasis properties, YAP activation and cytokinesis defects.

SUBMITTER: Keller M 

PROVIDER: S-EPMC6461807 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells.

Keller Maureen M   Dubois Fatéméh F   Teulier Sylvain S   Martin Alexandre P J APJ   Levallet Jérôme J   Maille Elodie E   Brosseau Solenn S   Elie Nicolas N   Hergovich Alexander A   Bergot Emmanuel E   Camonis Jacques J   Zalcman Gérard G   Levallet Guénaëlle G  

Journal of experimental & clinical cancer research : CR 20190412 1


<h4>Background</h4>RASSF1A, a tumor suppressor gene, is frequently inactivated in lung cancer leading to a YAP-dependent epithelial-mesenchymal transition (EMT). Such effects are partly due to the inactivation of the anti-migratory RhoB GTPase via the inhibitory phosphorylation of GEF-H1, the GDP/GTP exchange factor for RhoB. However, the kinase responsible for RhoB/GEF-H1 inactivation in RASSF1A-depleted cells remained unknown.<h4>Methods</h4>NDR1/2 inactivation by siRNA or shRNA effects on epi  ...[more]

Similar Datasets

| S-EPMC4136486 | biostudies-literature
| S-EPMC6872931 | biostudies-literature
| S-EPMC5004678 | biostudies-literature
| S-EPMC133879 | biostudies-literature
| S-EPMC4875310 | biostudies-literature
| S-EPMC3797720 | biostudies-literature
| S-EPMC2776651 | biostudies-literature
| S-EPMC7766191 | biostudies-literature
| S-EPMC34698 | biostudies-literature